Since the publication of the recommended procedure for the diagnosis and treatment of primary biliary cholangitis in 2018 [1], new information has emerged that affects the indications for treatment in patients with this disease. The ČHS ČLS JEP committee therefore decided to issue an update to the mandate for point: potential second-line treatment - obeticholic acid (OCA).